Torley Helen

CIK 00015281854 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001528185

Recent Transactions

50 trades

Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-03-04$12.07/sh−10,000→ 151,923 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-04$12.07/sh+10,000→ 777,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-04$69.94/sh−7,329→ 770,451 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-04$70.94/sh−2,671→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-03$69.33/sh−6,519→ 767,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-03$12.07/sh+20,000→ 787,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-03$68.85/sh−13,481→ 774,299 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-03-03$12.07/sh−20,000→ 161,923 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-02$12.07/sh+20,000→ 787,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-02$70.46/sh−578→ 767,780 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-02$69.20/sh−4,100→ 783,680 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-03-02$69.80/sh−15,322→ 768,358 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-03-02$12.07/sh−20,000→ 181,923 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-23+22,436→ 779,884 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-23$70.64/sh−12,104→ 767,780 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-23−22,436→ 44,872 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-20+16,757→ 766,488 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-20$70.98/sh−9,040→ 757,448 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-20−16,757→ 50,270 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+16,875→ 735,269 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-16−16,875→ 16,874 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−11,334→ 718,394 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-16−51,171→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+21,009→ 729,728 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-16−21,009→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−27,605→ 749,731 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−9,104→ 726,165 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+51,171→ 777,336 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-02-09+53,847→ 53,847 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-09+50,013→ 50,013 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+19,807→ 51,171 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+24,985→ 144,400 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+92,714→ 92,714 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-05$78.38/sh−5,376→ 713,343 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-02-05$12.07/sh−10,000→ 201,923 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-05$78.94/sh−4,624→ 708,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-05$12.07/sh+10,000→ 718,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-04$12.07/sh+20,000→ 728,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-04$77.54/sh−10,100→ 708,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-02-04$12.07/sh−20,000→ 211,923 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-04$76.94/sh−9,900→ 718,819 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-03$76.73/sh−7,790→ 708,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-03$12.07/sh+20,000→ 728,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-03$74.88/sh−2,551→ 726,168 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-02-03$12.07/sh−20,000→ 231,923 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-03$75.94/sh−9,659→ 716,509 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-12-09+165,522→ 165,522 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-12-01$8.11/sh−16,569→ 0 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$68.51/sh−10,406→ 714,882 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$71.60/sh−261→ 708,719 total

Companies

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov